medigraphic.com

2005, Number 3

<< Back Next >>

Arch Cardiol Mex 2005; 75 (3)

Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction

Arias EA, González-Chon O, García-López SMC, Chacón MA, Noriega-Iriondo F, Vega RE, Chávez-Tapia NC

Language: Spanish
References: 30
Page: 260-266
PDF size: 79.93 Kb.


ABSTRACT

Objective: To determine the impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock post-acute myocardial infarction. Methods: In a two-year period, 292 patients with acute myocardial infarction were admitted to the coronary intensive care unit, 40 were included in the study. Afterwards, patients were divided in two groups: early cardiogenic and late cardiogenic shock, and they were assigned randomly and blind to treatment with inotropics and inotropics plus intra-aortic balloon pump. Results: There were significant differences in the measurements of pulmonary wedge pressure (20.4 ± 1.6 vs 24.4 ± 1.50, p = 0.0004) and the cardiac index (2.06 ± 0.7 vs 1.65 ± 0.18, p = 0.0002) between the two groups. The late cardiogenic shock group showed an increased mortality (25.9% vs 61.5%, p ‹ 0.05). Patients treated with inotropics + balloon, in both early and late shock groups, showed a reduction in mortality of 66% and 69%, respectively. Conclusions: The use of the intra-aortic balloon pump in the treatment of cardiogenic shock post acute myocardial infarction reduces the mortality when associated with the use of inotropics and reperfusion. (Arch Cardiol Mex 2005; 75: 260-266)


REFERENCES

  1. Ohman EM, Califf RM, George BS: Use of intraaortic balloon pumping as adjunct to reperfusion therapy in acute myocardial infarction: the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trial Study Group. Am Heart J 1991; 121: 895-901.

  2. Ishihara M, Sato H, Tateishi H: Intraaortic balloon pumping as a post angioplasty strategy in acute myocardial infarction. Am Heart J 1991; 122: 385-9.

  3. Lincoff AM, Popma SJ, Ellis SG: Percutaneous support devices for high risk or complicated angioplasty. J Am Coll Cardiol 1991; 17: 770-5.

  4. Moulopoulos SD, Topaz S, Kolff WJ: Diastolic balloon pumping (with carbon dioxide) in the aorta: Mechanical assistance to the failing circulation. Am Heart J 1962; 62: 669-672.

  5. Marcus ML: Intraaortic balloon counterpulsation. En: Marcus, ML: The coronary circulation in health and disease. Nueva York. McGraw-Hill, 1983: 390-395.

  6. González-Chon O: Manual de contrapulsación aórtica. México. Ed. Ciencia y Cultura Latinoamericana; 1988: 33-36.

  7. Marchionni N, Fumagalli S, Baldereschi G: Effective arterial elastance and the hemodynamic effects of intraaortic balloon counterpulsation in patients with coronary heart disease. Am Heart J 1998; 135: 855-61.

  8. Weber KT, Janicki JS: Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety. Ann Thorac Surg 1974; 17: 602-36.

  9. González-Chon O: Indicaciones para el uso de balón de contrapulsación aórtica. En: Complicaciones en la terapia postquirúrgica cardiovascular. México. Ed. Manual moderno, 2002: 139-52.

  10. Lupi HE, Abundes VA, Martínez EA, Martínez GL: Choque cardiogénico. Rev Mex Cardiol 2000; 11: 254-269.

  11. Kern MJ, Aguirre FV, Tatineni S: Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993; 21: 359-68.

  12. Williams DO, Korr KS, Gewirtz H, Most AS: The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982; 66: 593-7.

  13. Port SC, Patel S, Schmidt DH: Effects of intraaortic balloon counterpulsation on myocardial blood flow in patients with severe coronary artery disease. J Am Coll Cardiol 1984; 3: 1367-74.

  14. Kern MJ, Aguirre FV, Bach R: Augmentation of coronary blood flow by intraaortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87: 500-5.

  15. Hurtado L, Santomé JA, Fernández C, Cárdenas M: Infarto agudo del miocardio con choque cardiogénico. Arch Inst Cardiol Mex 1984; 54: 121-9.

  16. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM: Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340: 1162–1168.

  17. Hochman JS, Buller CE, Sleeper LA: Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1063–1070.

  18. Barron HV, Every NR, Parsons LS: The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141: 933-939.

  19. Kovack PJ, Rasak MA, Bates ER: Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997; 29: 1454-1458.

  20. O’Rourke MF, Norris RM, Campbell TJ, Chang VP, Sammel NL: Randomized controlled trial on intra-aortic balloon counterpulsation in early myocardial infartion with acute heart failure. Am J Cardiol 1981; 47: 815-820.

  21. Flaherty JT, Becker LC, Weiss JL: Results of randomized prospective trial of intra-aortic ballon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infartion. J Am Coll Cardiol 1985; 6: 434-436.

  22. Hochman JS, Sleeper LA, Webb JG: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 625–634.

  23. Waksman R, Weiss AT, Gotsman MS: Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J 1993; 14: 71-74.

  24. Hochman JS, Sleeper LA, White HD: One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: 190-192.

  25. Barron HV, Every NR, Parsons LS: The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141: 933-939.

  26. Jollis JG, Peterson ED, DeLong ER: The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med 1994; 331: 1625-1629.

  27. Magid DJ, Calonge BN, Rumsfeld JS: Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 2000; 284: 3131-3138.

  28. Sanborn TA, Sleeper LA, Bates ER: Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1123-1129.

  29. Anderson RD, Ohman EM, Holmes DR Jr: Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 708-715.

  30. Hasdai D, Holmes DR Jr, Topol EJ: Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur Heart J 1999; 20: 128-135.




2020     |     www.medigraphic.com